Adaptation and Psychometric Validation of the Child and Adolescent Forms of the Glasgow Antipsychotic Side-Effect Scale (GASS)
This study successfully adapted the Glasgow Antipsychotic Side-Effect Scale into Turkish for children and adolescents, confirming its validity and reliability while demonstrating that a subscale-based profile approach is more clinically informative than a total score for assessing antipsychotic side effects in this population.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Medications that calm the mind are a cornerstone of modern psychiatry, helping millions of children and teenagers manage conditions ranging from severe mood swings to autism spectrum disorders. These drugs, known as antipsychotics, work by adjusting the brain's chemical signals, but they often come with a heavy price: a wide array of physical side effects. Children might feel unusually sleepy, gain weight rapidly, or experience stiff muscles and tremors. Because growing bodies process medicine differently than adult bodies, the way these side effects appear and feel can be unique to youth. Yet, for a long time, doctors have lacked a simple, reliable way to ask children and their parents exactly what is happening. Without a clear picture of these side effects, families often stop taking necessary medication, leaving the underlying condition untreated and the child vulnerable.
To solve this, a team of researchers in Turkey set out to create a specialized tool for the youngest patients. They took an existing questionnaire designed for adults, called the Glasgow Antipsychotic Side-Effect Scale, and carefully adapted it for two distinct age groups: children aged six to twelve, and teenagers aged thirteen to seventeen. The researchers understood that a six-year-old cannot describe their symptoms the same way a sixteen-year-old can, and that parents often see things their children do not notice. So, they created two separate versions of the survey. The version for younger children was filled out by their parents, who act as the eyes and ears for symptoms the child might not articulate. The version for teenagers was designed for the young people to fill out themselves, capturing their personal experience of discomfort.
The team tested these new surveys on a group of 247 patients receiving antipsychotic treatment at a psychiatric clinic. The group included 119 children and 128 adolescents, with an average age of about twelve and a half years. Most of the children in the study were being treated for attention-deficit/hyperactivity disorder, while the teenagers were more often being treated for depression or anxiety. The researchers asked the participants to report on how often they experienced specific problems, such as feeling drowsy, gaining weight, or having trouble with movement, and whether these problems caused them distress. They then used statistical methods to see if the questions grouped together in a way that made sense, essentially checking if the survey was measuring what it claimed to measure.
The results showed that the surveys worked well, but they revealed a surprising truth about how side effects should be counted. In the adult version of the scale, doctors often add up all the answers to get a single total score that represents the overall burden of side effects. However, when the researchers applied this same logic to the children and teenagers, the math did not hold up. The data showed that adding everything together into one big number was misleading. Instead, the surveys naturally split into smaller, distinct groups of symptoms. For the younger children, the questions sorted themselves into three clear categories. For the teenagers, they formed four distinct categories. This means that a child might have a low total score but still be suffering terribly from one specific type of problem, like weight gain, which would be hidden if only the total number was looked at.
The researchers found that the most common and troubling side effect for both groups was weight gain. In the teenage group, nearly thirty percent reported that gaining weight was a significant source of distress. Sedation, or extreme sleepiness, was also a major issue for the teenagers. For the younger children, whose parents filled out the forms, movement-related problems were more frequently reported, though weight gain remained the top concern. The study confirmed that the way side effects are reported changes as a child grows older and that parents and children often notice different things. For instance, teenagers were more likely to report feeling sleepy, while parents of younger children were more likely to notice physical stiffness or tremors.
Crucially, the study argues against the idea that a single score can tell the whole story for a child or teenager. The researchers concluded that doctors should stop looking for one total number and instead look at the specific profile of symptoms. By examining the separate groups of symptoms, a doctor can see exactly what is bothering a patient. If a teenager is struggling with weight gain but not with movement issues, the treatment plan can be adjusted to address that specific problem without ignoring the rest. This approach allows for a more precise and humane way of monitoring health. The study did not find that the surveys were perfect; some questions had to be removed because they did not fit well with the others, and the researchers noted that they could not yet test how stable the results are over time. However, they established that these new, age-specific tools are valid and reliable, offering a much clearer window into the daily reality of young people taking antipsychotic medication.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.